Skip to main content

Michelle Kolb, MSN, CRNP

Michelle Kolb, MSN, CRNP

Michelle Kolb, MSN, CRNP, is a Nurse Practitioner in the Cancer Center at Children's Hospital of Philadelphia.

Areas of expertise: Hematologic malignancies, Blood and marrow transplantation

Locations: Main Building


215-590-3025

267-426-0762

About Michelle Kolb, MSN, CRNP

Titles

Nurse Practitioner

Certifications

Basic Cardiac Life Support (BCLS)

Certified Registered Nurse Practitioner (CRNP)

Pediatric Chemotherapy and Biotherapy Provider – Association of Pediatric Hematology/Oncology Nurses (APHON)

Awards and Honors

2013, Richard E. Witten Award for Volunteer Leadership, Columbia University

Leadership and Memberships

Memberships in Professional Organizations

- 2012-2015, BSI Collaborative Team Leader: National Association of Children’s Hospitals and Related Institutions

Editorial and Academic Positions

Academic and Institutional Committees

Columbia University School of Nursing
- 2012-present, Board of Officers & Directors

Giving Day Committee
-2013, Co-chairperson

2013-2014, Alumni Admissions Ambassador

2012-present, Columbia University School of Nursing, Instructor In Clinical Nursing, Division of Academics

Education & training

Undergraduate Degree

BSN - Columbia University, New York, NY
BA in Art Studio - Queens College, New York, NY

Graduate Degree

MSN, Pediatric Nurse Practitioner with subspecialty in Oncology, Columbia University, New York, NY

Team affiliations

View fewer all team affiliations View all all team affiliations

Publications

Publications

Bacterial bloodstream infections in pediatric allogeneic hematopoietic stem cell recipients before and after implementation of a central line-associated bloodstream infection protocol: A single-center experience. Am J Infect Control. 2016 Jul 1. pii: S0196-6553(16)30473-4

2016

Kolb M, Offer K, Jin Z, Kahn J, Bhatia M, Kung AL, Garvin JH, George D, Satwani P. Risk Factors for Subtherapeutic Tacrolimus Levels after Conversion from Continuous Intravenous Infusion to Oral in Children after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 May;22(5):957-61. doi: 10.1016/j.bbmt.2016.02.005. Epub 2016 Feb 13.

2014

Offer K, Kolb M, Jin Z, Bhatia M, Kung AL, George D, Garvin JH, Robinson C, Sosna J, Karamehmet E, Satwani P. Efficacy of tacrolimus/mycophenolate mofetil as acute graft-versus-host disease prophylaxis and the impact of subtherapeutic tacrolimus levels in children after matched sibling donor allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015 Mar;21(3):496-502. doi: 10.1016/j.bbmt.2014.11.679. Epub 2014 Dec 20.

Kolb M, Bhatia M, Madina GG, Satwani P. Effective use of tocilizumab for the treatment of steroid-refractory gastrointestinal acute graft versus host disease in a child with very high levels of serum interleukin-6. Pediatr Blood Cancer. 2014 Sep 11. doi: 10.1002/pbc.25231. [Epub ahead of print].

2009

Kolb, M.  Life After Pediatric Cancer: Easing the Transition to the Adult Primary Care Provider. Clinical Journal of Oncology Nursing, (2009), 13, 6.

Jump back to top